ST. LOUIS - (Mealey's) In a 2-1 ruling July 26, the Eighth Circuit U.S. Court of Appeals reversed summary judgment in two Prempro bellwether cases that involve the risk of breast cancer in women who took the hormone replacement therapy drug for less... Read More
ST. LOUIS -- (Mealey's) Claims that a drug company sold consumers an adulterated drug aren't preempted under two U.S. Supreme Court rulings, a panel of the Eighth Circuit U.S. Court of Appeals ruled Jan. 19 ( Allen LeFaivre, et al. v. KV Pharmaceutical... Read More
ST. PAUL, Minn. - (Mealey's) Determining that a jury award of $222,000 from almost five years ago was constitutional, an Eighth Circuit U.S. Court of Appeals panel on Sept. 11 reinstated the award in favor of a group of six plaintiff record labels... Read More
Consumers can sue a drug company for selling a drug that was not manufactured pursuant to good manufacturing practices (GMP) and was, thus, "adulterated" under the Food, Drug and Cosmetic Act (FDCA). Such claims are not preempted by federal... Read More
ST. LOUIS — (Mealey’s) The Eighth Circuit U.S. Court of Appeals on Nov. 30 unanimously affirmed denial of judgment as a matter of law or new trial for compensatory damages in the first Levaquin multidistrict litigation bellwether trial but... Read More
By Jacqueline N. Acosta In an August 7, 2014 opinion, the Eighth Circuit upheld the dismissal of a whistleblower’s suit alleging that a number of pain pump device makers had violated the False Claims Act (FCA) by marketing their pain pumps for... Read More
ST. LOUIS - (AP) Dairy consumers who sued several national chains and the largest U.S. provider of store-brand organic milk claiming they falsely labeled the milk can continue with their lawsuit under a federal appeals court ruling issued Wednesday. The... Read More